docj wrote:

I am two years post covid with several lingering symptoms. Like you, am also hoping they will do something with longhaulers eventually. I'd say it won't happen until an approval is in place for something else. Financial resources won't allow unless the NIH or someone else of that nature sees the value in studying. Very difficult end points to design a trial around. Perhaps the next "new" virus will move things along.


Read More: https://investorshangout.com/post/view?id=650...z7m8hVeKPz
________________

Not "perhaps" but confidently for sure. According to recent news from Boston University, our "gain-of-function" geniuses have succeeded in producing the next "new" modification of Omicron with 80% mortality and 30-fold more infectious. No wonder the Chinese are preparing for the worst with their "draconian" anti-Covid measures. Now it's only a matter of time. Leronlimab has a great future... unlike many of us.